Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Prevention of varicella: time for two-dose vaccination.

Macartney K.

Lancet. 2014 Apr 12;383(9925):1276-7. doi: 10.1016/S0140-6736(14)60078-7. Epub 2014 Jan 29. No abstract available.

PMID:
24485547
2.

Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.

Shinefield HR, Black S, Kuter BJ.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S152-5. doi: 10.1086/522126.

3.

Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Marin M, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12.

4.

[Combined vaccine against measles, mumps, rubella and varicella and recommendations for varicella immunization in Italy?].

Papa R, Spinelli R, Zaratti L, Franco E.

Ig Sanita Pubbl. 2007 Nov-Dec;63(6):715-22. Italian.

PMID:
18216886
5.

Measles-mumps-rubella-varicella combination vaccine (ProQuad): a guide to its use in children in the E.U.

Scott LJ.

Paediatr Drugs. 2015 Apr;17(2):167-74. doi: 10.1007/s40272-015-0123-7.

PMID:
25732634
6.

Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.

Parment PA, Svahn A, Rudén U, Bråkenhielm G, Storsaeter J, Akesson L, Linde A.

Scand J Infect Dis. 2003;35(10):736-42.

PMID:
14606613
7.

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial.

Prymula R, Bergsaker MR, Esposito S, Gothefors L, Man S, Snegova N, Stefkovičova M, Usonis V, Wysocki J, Douha M, Vassilev V, Nicholson O, Innis BL, Willems P.

Lancet. 2014 Apr 12;383(9925):1313-24. doi: 10.1016/S0140-6736(12)61461-5. Epub 2014 Jan 29.

PMID:
24485548
8.

[Chickenpox: sufficient reasons for the introduction of vaccination].

Rümke H, de Groot R.

Ned Tijdschr Geneeskd. 2006 Dec 2;150(48):2630-2. Dutch.

PMID:
17205937
9.

Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.

Knuf M, Zepp F, Helm K, Maurer H, Prieler A, Kieninger-Baum D, Douha M, Willems P.

Eur J Pediatr. 2012 Mar;171(3):463-70. doi: 10.1007/s00431-011-1569-4. Epub 2011 Sep 21.

PMID:
21935584
10.

The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.

Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ; Consistency Lot Study Group for ProQuad.

Pediatr Infect Dis J. 2006 Jul;25(7):615-22.

PMID:
16804432
11.

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.

Nolan T, McIntyre P, Roberton D, Descamps D.

Vaccine. 2002 Dec 13;21(3-4):281-9.

PMID:
12450703
12.

A combination vaccine against measles, mumps, rubella and varicella.

Knuf M, Faber J, Barth I, Habermehl P.

Drugs Today (Barc). 2008 Apr;44(4):279-92. Review.

PMID:
18536786
13.

[Does vaccination for chickenpox prevent herpes zoster? (interview by Waldtraut Paukstadt)].

Doerr HW.

MMW Fortschr Med. 2002 Dec 12;144(50):12. German. No abstract available.

PMID:
14610859
14.

Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.

Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P.

Pediatr Infect Dis J. 2008 Aug;27(8):724-30. doi: 10.1097/INF.0b013e318170bb22. Erratum in: Pediatr Infect Dis J. 2013 Apr;32(4):e163.

PMID:
18600190
15.

Assessing the introduction of universal varicella vaccination in the Netherlands.

Boot HJ, de Melker HE, Stolk EA, de Wit GA, Kimman TG.

Vaccine. 2006 Sep 11;24(37-39):6288-99. Epub 2006 Jun 8.

PMID:
16790302
16.

Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.

Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM; LAIV Study Group.

Pediatrics. 2008 Mar;121(3):508-16. doi: 10.1542/peds.2007-1064.

PMID:
18310199
17.

[Combined or coadministred Measles, Mumps, Rubella and Varicella Vaccines? That is the question!].

Laudati F, Zaratti L, Franco E.

Ig Sanita Pubbl. 2012 Mar-Apr;68(2):313-21. Italian.

PMID:
23064094
18.

Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Marin M, Güris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2007 Jun 22;56(RR-4):1-40.

19.
20.

Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.

Knuf M, Habermehl P, Zepp F, Mannhardt W, Kuttnig M, Muttonen P, Prieler A, Maurer H, Bisanz H, Tornieporth N, Descamps D, Willems P.

Pediatr Infect Dis J. 2006 Jan;25(1):12-8.

PMID:
16395096
Items per page

Supplemental Content

Write to the Help Desk